Article Menu
Need Help?
No Article Versions Notes Found
Cite
Thangarasa, T.; Gotfrit, J.; Goodwin, R.A.; Tang, P.A.; Clemons, M.; Imbulgoda, A.; Vickers, M.M. Epidermal Growth Factor Receptor Inhibitor–Induced Hypomagnesemia: A Survey of Practice Patterns among Canadian Gastrointestinal Medical Oncologists. Curr. Oncol. 2019, 26, 162-166. https://doi.org/10.3747/co.26.4591
Thangarasa T, Gotfrit J, Goodwin RA, Tang PA, Clemons M, Imbulgoda A, Vickers MM. Epidermal Growth Factor Receptor Inhibitor–Induced Hypomagnesemia: A Survey of Practice Patterns among Canadian Gastrointestinal Medical Oncologists. Current Oncology. 2019; 26(2):162-166. https://doi.org/10.3747/co.26.4591
Chicago/Turabian StyleThangarasa, T., J. Gotfrit, R.A. Goodwin, P.A. Tang, M. Clemons, A. Imbulgoda, and M.M. Vickers. 2019. "Epidermal Growth Factor Receptor Inhibitor–Induced Hypomagnesemia: A Survey of Practice Patterns among Canadian Gastrointestinal Medical Oncologists" Current Oncology 26, no. 2: 162-166. https://doi.org/10.3747/co.26.4591
APA StyleThangarasa, T., Gotfrit, J., Goodwin, R. A., Tang, P. A., Clemons, M., Imbulgoda, A., & Vickers, M. M. (2019). Epidermal Growth Factor Receptor Inhibitor–Induced Hypomagnesemia: A Survey of Practice Patterns among Canadian Gastrointestinal Medical Oncologists. Current Oncology, 26(2), 162-166. https://doi.org/10.3747/co.26.4591
